Financial Analysis: IM Cannabis (NASDAQ:IMCC) & Hero Technologies (OTCMKTS:HENC)

Institutional and Insider Ownership

7.7% of IM Cannabis shares are owned by institutional investors. 5.9% of IM Cannabis shares are owned by company insiders. Comparatively, 0.2% of Hero Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Profitability

This table compares IM Cannabis and Hero Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
IM Cannabis	-25.55%	-129.86%	-23.63%
Hero Technologies	N/A	N/A	N/A

Earnings & Valuation

This table compares IM Cannabis and Hero Technologies”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IM Cannabis	$51.39 million	0.08	-$7.04 million	($3.41)	-0.52
Hero Technologies	N/A	N/A	-$540,000.00	N/A	N/A

Hero Technologies has lower revenue, but higher earnings than IM Cannabis.

Volatility and Risk

IM Cannabis has a beta of 1.03, suggesting that its stock price is 3% more volatile than the S&P 500. Comparatively, Hero Technologies has a beta of 0.38, suggesting that its stock price is 62% less volatile than the S&P 500.

About IM Cannabis

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.

About Hero Technologies

Hero Technologies Inc. operates as an early-stage cannabis company. It focuses on the provision of BlackBox, an aeroponic cannabis cultivation system that provides optimal growing conditions to enhance photosynthesis and the cultivation of large flowering plants and create increased harvest efficiencies. The company also intends to offer cannabis genetic engineering farmland for medical and recreational cannabis cultivation, production, distribution, packaging, and retail operations, as well as for dispensaries. The company is based in Dover, Delaware.